 The intervention group will have better experienced quality and higher HeQoL. End points: Score concerning HeQoL and patient experienced quality. Material Method: Same method and study population as in study 2. Disease-specific questionnaires from the European Organisation for Research and Treatment of Cancer, EORTC QLQ-BLM30 and QLQ-C30 42 were applied. Scores are made at baseline and follow-up at planned control visits 35 days, 120 days and 365 days. At discharge EORTC In-PATSAT32 is used to evaluate the patient experience of quality during admission. All questionnaires are validated and translated into Danish 43,44. 